Publications
Export 79 results:
Filters: Author is M-A Roy [Clear All Filters]
, “Cognitive structure from childhood to adulthood in kindreds densely affected by schizophrenia and bipolar disorder.”, Psychiatry Res, vol. 229, no. 1-2, pp. 101-8, 2015.
, “Comorbidity between anxiety disorders and recent-onset psychotic disorders.”, Schizophr Res, vol. 166, no. 1-3, pp. 353-4, 2015.
, “Social anxiety disorder in recent onset schizophrenia spectrum disorders: The relation with symptomatology, anxiety, and social rank.”, Psychiatry Res, vol. 227, no. 1, pp. 39-45, 2015.
, “Top-down computerized cognitive remediation in schizophrenia: a case study of an individual with impairment in verbal fluency.”, Case Rep Psychiatry, vol. 2015, p. 242364, 2015.
, “Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.”, Eur Arch Psychiatry Clin Neurosci, vol. 264, no. 4, pp. 333-43, 2014.
, “Extension of the generalized disequilibrium test to polytomous phenotypes and two-locus models.”, Front Genet, vol. 5, p. 258, 2014.
, “Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples.”, Biol Psychiatry, vol. 74, no. 6, pp. 444-50, 2013.
, “Impact of social anxiety on social cognition and functioning in patients with recent-onset schizophrenia spectrum disorders.”, Schizophr Res, vol. 145, no. 1-3, pp. 75-81, 2013.
, “The influence of visual perspective on the somatosensory steady-state response during pain observation.”, Front Hum Neurosci, vol. 7, p. 849, 2013.
, “Long-acting injectable antipsychotics: evidence of effectiveness and use.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 5S-13S, 2013.
, “Long-acting injectable antipsychotics: recommendations for clinicians.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 30S-5S, 2013.
, “A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 23S-9S, 2013.
, “A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 14S-22S, 2013.
, “Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics.”, Australas Psychiatry, vol. 20, no. 2, pp. 138-42, 2012.
, “Detection of phenotype modifier genes using two-locus linkage analysis in complex disorders such as major psychosis.”, Hum Hered, vol. 73, no. 4, pp. 195-207, 2012.
, “Mentalizing in first-episode psychosis.”, Psychiatry Res, vol. 196, no. 2-3, pp. 207-13, 2012.
, “Principal components of heritability for high dimension quantitative traits and general pedigrees.”, Stat Appl Genet Mol Biol, vol. 11, no. 2, 2012.
, “Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder.”, Eur J Hum Genet, vol. 20, no. 11, pp. 1182-8, 2012.
, “Time perception disorders are related to working memory impairment in schizophrenia.”, Psychiatry Res, vol. 200, no. 2-3, pp. 159-66, 2012.
, “Assessment of empathy in first-episode psychosis and meta-analytic comparison with previous studies in schizophrenia.”, Psychiatry Res, vol. 190, no. 1, pp. 3-8, 2011.
, “[Cognitive-behavioural therapy in early psychosis: an open study in a clinical setting].”, Can J Psychiatry, vol. 56, no. 1, pp. 51-61, 2011.
, “How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.”, Schizophr Bull, vol. 37, no. 4, pp. 811-21, 2011.
, “[Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec].”, Can J Psychiatry, vol. 56, no. 6, pp. 367-76, 2011.
, “The role of recollection in source memory: an examination of schizophrenia patients and their first-degree relatives.”, Brain Cogn, vol. 75, no. 2, pp. 147-53, 2011.
